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Objective: This study examined the course and predictors of supportive care needs
among Mexican breast cancer patients for different cancer treatment trajectories.
Methods: Data from 172 (66.4% response rate) patients were considered in this
observational longitudinal study. Participants were measured after diagnosis, neoadju-
vant treatment, surgery, adjuvant treatment, and the first post‐treatment follow‐up
visit. Psychological, Health System and Information, Physical and Daily Living, Patient
Care and Support, Sexual, and Additional care needs were measured with the
Supportive Care Needs Survey (SCNS‐SF34). Linear mixed models with maximum‐
likelihood estimation were computed.
Results: The course of supportive care needs was similar across the different cancer
treatment trajectories. Supportive care needs declined significantly from diagnosis to
the first post‐treatment follow‐up visit. Health System and Information care needs
were the highest needs over time. Depressive symptoms and time since diagnosis
were the most consistent predictors of changes in course of supportive care needs
of these patients.
Conclusions: Health system and information care needs of Mexican breast cancer
patients need to be addressed with priority because these needs are the least met.
Furthermore, patients with high depressive symptoms at the start of the disease tra-
jectory have greater needs for supportive care throughout the disease trajectory.
KEYWORDS
breast cancer, Latinas, needs assessment, oncology, supportive care1 | BACKGROUND
Supportive care refers to the care provided along with the medical
treatment at any point during the disease trajectory, and it is focused
on meeting the patients' psychological, spiritual, supportive, informa-
tional, and practical needs.1 In Latin America, where 7.8% of world-
wide new cancer cases occur and resources allocated to health care- - - - - - - - - - - - - - - - - - - - - - - - - - -
e Creative Commons Attribution Li
by John Wiley & Sons Ltd.are generally limited, the implementation of supportive care is not
common practice and is often a low priority.2,3 Identifying the priority
care needs of these cancer patients is relevant to improve care provi-
sion, especially in Mexico, where breast cancer is highly prevalent and
it is among the 3 leading causes of death in Mexican women.4,5
However, there are no previous longitudinal studies addressing sup-
portive care needs of cancer patients in Latin America. Longitudinal- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
cense, which permits use, distribution and reproduction in any medium, provided
Psycho‐Oncology. 2018;27:2132–2140.
PÉREZ‐FORTIS ET AL. 2133research among Asian and European breast cancer patients showed
that supportive care needs may change during active treatment,6,7
and in the survivorship phase.8 Besides, cross‐sectional research
showed differences in unmet care needs between Asian and European
breast cancer patients.9
A longitudinal study among Taiwanese breast cancer patients in
early stages of the disease and undergoing active treatment showed
that supportive care needs decreased from diagnosis up to 3‐month
follow‐up post‐diagnosis.6 By contrast, another study with Chinese
breast cancer patients in more advanced stages of the disease receiv-
ing chemotherapy (baseline) and who were followed up to 12‐months
post‐baseline showed that most patients reported stable low needs in
all the supportive care needs domains, with only a few patients show-
ing an increase in care needs for the Psychological and Physical and
Daily Living domains.7 Supportive care needs among French breast
cancer survivors evaluated in the last week of primary treatment and
4 and 8 months later showed low decreasing Health System and
Information care needs, medium stable Psychological or Physical and
Daily Living care needs, low stable Patient Care and Support needs,
and no need stable Sexual care needs.8 These findings show that
supportive care needs may fluctuate in breast cancer patients under
treatment or in the survivorship phase. However, interpretation of
their relevance for clinical practice is complicated because measure-
ments were scheduled on a time‐basis from diagnosis or baseline mea-
sure, without considering that key meaningful events (eg, neoadjuvant
treatment, surgery, adjuvant treatment) occur in different moments
for each patient during active treatment and may elicit care needs.
Additionally, these studies did not distinguish between the different
treatment trajectories, included only patients in an advanced stage
of the disease7 or in the survivorship phase,8 which prevents us from
getting a complete picture of the supportive care needs throughout
different disease trajectories.
The present study assessed the course of supportive care needs
among Mexican breast cancer patients with measurements scheduled
after meaningful events. More precisely, we wanted to investigate
whether the course of supportive care needs was different for
patients depending on the treatment trajectory they followed (ie,
group A: only surgery, group B: surgery plus adjuvant treatment, or
group C: neoadjuvant treatment, surgery, and adjuvant treatment).
Additionally, we explored potential predictors of changes in the sup-
portive care needs of Mexican breast cancer patients, as earlier
cross‐sectional and longitudinal research among cancer patients
showed that sociodemographic, psychological, and medical character-
istics were related to care needs.7,8,102 | METHODS
2.1 | Design
We conducted an observational longitudinal study with measure-
ments scheduled after diagnosis, after finishing each treatment
modality, and at the first post‐treatment follow‐up visit. Breast cancer
patients differ in treatment trajectories depending on cancer stage
and several prognostic factors.11 Overall, patients with advancedcancer stages and worse prognostic factors follow more intensive
treatment trajectories compared with patients with earlier cancer
stages or better prognostic factors. Thus, treatment trajectories are
intertwined with cancer stage. Based on the treatment trajectories
that the patients in our study followed, we identified 3 groups. Group
A are the patients who followed surgery only, after the diagnosis.
Group B are the patients who followed surgery and adjuvant treat-
ment. Group C are the patients who followed neoadjuvant treatment,
surgery, and adjuvant treatment. The assessments were conducted
after diagnosis but before surgery (T1); after end of neoadjuvant
treatment (T2); after surgery and before start of adjuvant treatment
(T3); at the end of the adjuvant treatment (either chemotherapy,
radiotherapy or the combination of both) (T4); at first post‐treatment
follow‐up appointment (T5). Depending on these treatment trajecto-
ries, patients had 3 (group A), 4 (group B), or 5 measurements (group
C). Some patients within each group were following hormone therapy,
but this treatment was not taken into account in the study due to its
long duration.2.2 | Participants and procedure
After approval from the research and ethics committee of the hospital
(R‐2014‐3504‐40), breast cancer patients were recruited consecu-
tively in a public hospital in Mexico City from May 2014 to July
2015. Data collection was completed in November 2016. Inclusion
criteria were (1) age between 18 and 75 years, (2) first breast cancer
diagnosis, confirmed by a biopsy test, and (3) comprehension of
Spanish. Exclusion criteria were (1) presence of a psychiatric disorder
that implied hospital admission, (2) having a cancer recurrence, (3)
already had surgery, (4) participation in another study at time of inclu-
sion, and (5) being male.
After patients provided written informed consent, they were
approached and mainly face‐to‐face interviewed in the hospital and
a few by telephone (T2: 1.2%, T3: 4.7%, T4: 8.1%, T5: 7.6%) by 3 grad-
uated psychologists. The whole follow‐up lasted between 4 and
20 months, depending on the treatment trajectory of each patient. A
flowchart of the patient's participation in the study is shown in
Figure 1. Further details about the sample recruitment can be
consulted elsewhere.122.3 | Measurements
Supportive care needs were measured at each measure point with the
Supportive Care Needs Survey ‐short form‐ (SCNS‐SF34).13 The
instrument consists of 5 subscales, Psychological (10 items), Health
System and Information (11 items), Physical and Daily Living (5
items), Patient Care and Support (5 items), and Sexual (3 items) care
needs. For this study, we added an extra dimension that we labeled
as “Additional needs” (5 items) from the long version of the SCNS14
and refers to financial and practical difficulties. Thus, we used 39
items to measure the patients' level of need for help over 2 weeks
preceding the interview. Details on the adaptation of the instrument
to the Spanish version can be found elsewhere.12 The instrument
employs a 5‐point Likert response scale to rate the intensity of each
need, that is, 1 = Not applicable, 2 = Satisfied, 3 = Low need,
FIGURE 1 Flow chart of the patients' follow‐up
2134 PÉREZ‐FORTIS ET AL.4 = Moderate need, and 5 = High need. A total score for each
dimension was computed using standardized scores, which ranged
from 0 to 100. Higher scores reflected higher supportive care
needs.15 Cronbach alphas for the subscales at baseline ranged from
.69 to .95.
Anxiety symptoms were measured at baseline with the short form
of the Spielberg State and Trait Anxiety Inventory.16 This version
employs 6 items from the state subscale of the long original version.
We used the equivalent 6 items from the Spanish version of the
instrument.17 A total score is obtained summing all the items after
the negatives items have been properly transformed. Higher scores
indicate higher levels of anxiety (1 = not at all, 4 = very much).
Cronbach alpha for the scale was.81.Depressive symptoms were measured at baseline with the Spanish
version for Mexico of the Patient Health Questionnaire (PHQ‐9).18
The 9‐items instrument assesses depression severity experienced by
patients in the last 2 weeks. A total score is obtained summing all
the items. Higher scores indicate higher levels of depression (0 = not
at all, 3 = nearly every day). Cronbach alphas for the scale was .82.
Physical symptoms of the disease experienced by the patients
were measured after the surgery with the European Organization for
Research and Treatment of Cancer: Breast Cancer Specific Quality
of Life Questionnaire Module, Spanish version for Mexico (EORTC
QLQ‐BR23).19 We used the 3 symptoms scales: systemic therapy side
effects (7 items), breast symptoms (4 items), and arm symptoms (3
items). The response scale ranges from 1 = not at all to 4 = very much.
PÉREZ‐FORTIS ET AL. 2135Higher scores represent higher physical symptoms. Cronbach alphas
for the scales ranged from .60 to.71.
At baseline, we also collected data on age, number of children, mar-
ital status, education level, work status, and life events during the last
3 months and whether patients were receiving psychological aid at the
moment of the interview.Marital status was classified into with partner
(married/living together/in a relationship) and without partner (single/
widow/divorced); education level was classified into high (bachelor/
postgraduate studies), middle (secondary/technical high school), low
(without studies/primary); work status was classified into housewife
or employed, and life events into yes or not. We also collected
information on comorbidities, type of treatment and cancer stage.2.4 | Statistical analyses
We computed descriptive statistics of the sample characteristics per
cancer treatment group. ANOVAs and chi‐square tests were run to
compare the baseline characteristics of each group. To analyze the
longitudinal course of supportive care needs, we computed linear
mixed models with maximum‐likelihood estimation for each subscale
separately, including group, time, and their interaction. Time is the
number of days since diagnosis, and it was treated as a continuous
variable because the lapse between each measuring point varied forFIGURE 2 Supportive care needs course in the different medical treatmeach patient. We computed both, models with random intercept and
random slope, and models with random intercept only. We used
Akaike information criterion (AIC) and Bayesian information criterion
(BIC) to select the best possible model. Lower values of AIC/BIC
indexes were considered as indicative of a better model. According
to these criteria, only the intercept was considered to be random in
models for psychological, health system and information, physical
and daily living, patient care and support, and sexual dimensions;
whereas a random intercept and random slope were considered for
additional care needs dimension. Subsequently, predictors of the sup-
portive care needs' course were identified through univariate analyses.
Those sociodemographic, physical, and psychological variables (anxi-
ety and depressive symptoms at baseline), which were significantly
related to specific supportive care needs subscale, in at least 2 mea-
surement points were included. We recomputed linear mixed models
including group, time, time × group, and the predictors for each sub-
scale. When the interaction time × group was not significant, the
model was recomputed again without the interaction. AIC/BIC
decreased whenever the interaction term was removed. All patients
with at least 1 observation in the measure points and with measured
values of all predictors values at baseline were included in each model.
Analyses were conducted with SPSS version 24. P‐values were 2‐
sided with a significant level of 0.05.ent trajectory groups
2136 PÉREZ‐FORTIS ET AL.3 | RESULTS
3.1 | Characteristics of the sample
Details about the flow of patients are shown in Figure 1. A total of
172 patients (66.4% response rate) agreed to participate and were
assessed at baseline. Seventeen patients (9.9%) dropped out after
T1. The remaining patients were classified into 3 groups based on
the cancer treatment trajectory they followed: 29 in group A, 70
in group B, and 56 in group C (of whom 5 palliative patients were
evaluated every 3 months after measure T2). Duration of patients'
participation within the different groups differed significantly (for
A, B, and C, respectively, on average 10 (SD = 3.7), 15.2 (SD = 3.5),
and 16.7 (SD = 2.9) months, P ≤ 0.001). On average, patients were
53 years old, had middle education (60%), and had a partner (67%).
Cancer stage was significantly associated to group classification,
most patients with cancer stage III or IV were allocated to group
C. Further details on the sample's characteristics are in supporting
Table 1.3.2 | Course of supportive care needs
For all domains, except for the Health System and Information domain
in which scores ranged from moderate to low over time, scores rangedFIGURE 2 Continued.from low to no need over time (supporting table 2). The top 5 unmet
needs of each domain are shown in supporting table 3. Focusing on
the changes within groups, we observed a decrease in Psychological
care needs over time for all groups (Figures 2A1‐2A3), but this
decrease was only statistically significant for groups B and C. Health
System and Information care needs also showed a significant decrease
over time in all groups (Figures 2B1‐2B3). Physical and Daily Living
care needs did not change significantly over time in any of the groups
(Figures 2C1‐2C3). We observed a decrease in Patient Care and Sup-
port needs for all groups, but it was statistically significant only for
groups B and C (Figures 2D1‐2D3). The course of Sexual care needs
for groups A and B was low without significant changes over time,
but there was a significant small decrease over time for group C
(Figures 2E1‐2E3). The Additional care needs showed a significant
decline pattern in all 3 groups (Figures 2F1‐2F3).
The interaction between days since diagnosis (time) and treat-
ment trajectory (group) was not significant for any of the supportive
care needs dimensions, suggesting that the changes on the course of
supportive care needs were similar across the cancer treatment trajec-
tories. However, we observed a significant difference in the level of
Patient Care and Support dimension at T1 between the treatment tra-
jectories of group A and group C (Table 1). On average, patients from
group A at T1 started with lower levels in this dimension (Figure 2D1),
compared with patients from group C (Figure 2D3, P = 0.02).
TABLE 1 Linear mixed models' parameter estimates for the course of supportive care needs
Time Group Time × Group
(95% CI) (95% CI)
Supportive care needs' domains Estimate Lower Upper P Estimate Lower Upper P P
Psychological
Group A −0.03 −0.07 0.004 0.085 2.36 −9.83 14.55 0.704 0.953
Group B −0.03 −0.04 −0.01 < 0.001 3.07 −6.14 12.28 0.512 0.792
Group C −0.03 −0.04 −0.02 < 0.001
Health system/information
Group A −0.06 −0.10 −0.02 0.004 4.71 −8.62 18.04 0.487 0.368
Group B −0.05 −0.07 −0.04 < 0.001 5.99 −4.07 16.04 0.242 0.332
Group C −0.04 −0.06 −0.02 < 0.001
Physical/daily living
Group A 0.01 −0.02 0.05 0.468 0.93 −9.94 11.80 0.866 0.603
Group B −0.01 −0.02 0.01 0.354 4.57 −3.61 12.75 0.273 0.366
Group C 0.003 −0.01 0.02 0.701
Patient care/support
Group A −0.01 −0.04 0.03 0.745 −13.50 −25.03 −.197 0.022 0.074
Group B −0.03 −0.05 −0.02 < 0.001 −5.50 −14.18 3.18 0.213 0.257
Group C −0.04 −0.06 −0.03 < 0.001
Sexual
Group A −0.01 −0.04 0.03 0.776 2.84 −7.83 13.51 0.601 0.601
Group B −0.01 −0.02 0.001 0.073 5.11 −2.92 13.15 0.211 0.742
Group C −0.01 −0.03 −0.001 0.040
Additional
Group A −0.05 −0.09 −0.01 0.013 5.55 −8.15 19.25 0.425 0.476
Group B −0.03 −0.04 −0.01 0.001 3.12 −7.30 13.54 0.555 0.685
Group C −0.03 −0.05 −0.02 < 0.001
Note: Group C was the reference group. Time is the number of days since diagnosis.
PÉREZ‐FORTIS ET AL. 21373.3 | Predictors of supportive care needs
After adjusting linear mixed models by potential predictors, results
showed that, in general, patients with higher levels of depressive or
anxiety symptoms after diagnosis, those who received psychological
aid at T1, and those with higher systemic therapy side effects after
surgery showed higher care needs in specific domains over time.
Specifically, older patients indicated lower Sexual care needs over
time. Also, patients with a partner and those who followed surgery
(Group A) or surgery plus adjuvant treatment (group B), showed higher
Sexual care needs over time. The interaction time × group was not
significant for any of the dimensions. Further details about predictors
are inTable 2, which shows the significance and size of the fixed effects.4 | DISCUSSION
This study was the first to examine the course of supportive care
needs among Mexican breast cancer patients looking at differences
in cancer treatment and potential predictors of changes in supportive
care needs. Results showed that, overall the course of supportive care
needs did not differ by the cancer treatment trajectory. Supportive
care needs declined over time and patients reported relatively low
scores. Only the levels of Health System and Information care needs
were elevated over time. Depressive symptoms after diagnosis werethe most consistent predictor of change in supportive care needs
over time.
In general, supportive care needs of the patients were low and
decreased over time, which is in line with previous studies among
Chinese, Taiwanese, and French breast cancer patients.6-8 This might
suggest that patients' needs are met; either they receive the care they
require from the health system or they manage themselves to get the
help they need outside, particularly within a collectivistic culture like
Mexico, where social relationships and attachment between family
members is highly present. Health System and Information care needs
were the highest throughout time. This is consistent with previous
studies among Asian patients,6,7 but in contrast with studies among
Caucasian patients where Psychological needs were also high.8,20 This
difference might be explained by the differences in the health care
systems. Within the Mexican public health system is not common that
patients receive extensive information about their illness and their
care, consultations are rather short, and patients are not provided with
brochures or leaflets about their medical condition. Thus, our findings
indicate that it would be relevant to fit these aspects within the
Mexican health system and to provide clear information for all breast
cancer patients independent of their education level.
The only significant difference we found among patients differing
in cancer treatment was a higher Patient Care and Support need at the
time of diagnosis among patients who underwent neoadjuvant








Time −0.03*** −0.04 −0.02
Group (A vs C) 3.52 −4.09 11.14
Group (B vs C) 0.50 −5.60 6.60
Life events 0.85 −5.65 7.35
Anxiety 1.39*** 0.64 2.14
Depression 1.44*** 0.91 1.97
Psychological aid 15.60* 3.87 27.33
Side therapy effects 0.06 −0.12 0.23
Breast symptoms 0.08 −0.06 0.22
Arm symptoms 0.03 −0.10 0.16
Health system/information
Time −0.05*** −0.06 −0.04
Group (A vs C) −0.63 −10.88 9.62
Group (B vs C) 0.63 −7.26 8.51
Anxiety 0.65 −0.37 1.67
Depression 0.84* 0.14 1.53
Physical/daily living
Time −0.002 −0.01 0.01
Group (A vs C) 2.44 −4.37 9.26
Group (B vs C) 0.65 −4.79 6.08
Life events 3.19 −2.64 9.01
Anxiety 0.87* 0.19 1.54
Depression 0.89*** 0.41 1.37
Systemic therapy side effects 0.17* 0.02 0.33
Breast symptoms 0.04 −0.08 0.17
Arm symptoms 0.08 −0.04 0.19
Patient care/support
Time −0.04*** −0.05 −0.03
Group (A vs C) −7.59 −15.85 0.68
Group (B vs C) −4.40 −10.67 1.87
Anxiety 0.45 −0.36 1.27
Depression 0.94** 0.38 1.49
Sexual
Time −0.01* −0.02 −0.002
Group (A vs C) 7.44* 0.04 14.85
Group (B vs C) 7.20* 1.64 12.76
Age −0.34* −0.61 −0.06
Marital status 11.77*** 6.35 17.18
Education (low vs high) −9.57 −19.99 0.84
Education (middle vs high) −2.67 −11.75 6.40
Psychological aid 10.67 −1.94 23.29
Additional
Time −0.04*** −0.05 −0.02
Group (A vs C) 0.66 −7.80 9.11
Group (B vs C) 0.04 −6.11 6.19
Life events 3.62 −3.34 10.57
Anxiety 0.77 −0.03 1.56
Depression 1.29*** 0.75 1.83
Breast symptoms 0.12 −0.02 0.25
*P < .05. **P < .01. ***P < .001.
2138 PÉREZ‐FORTIS ET AL.treatment, surgery, and adjuvant treatment, compared with those who
only underwent surgery. This result may be because these patients
were in advanced disease stages. Our findings contradict previous
cross‐sectional studies showing differences in the health system and
information,21 physical and daily living,22 and psychological care
needs9 by the type of treatment received. This difference in results
might be explained by the fact that we analyzed the effect of the
whole cancer treatment trajectory on the course of supportive care
needs, and the previous studies reported the single effect of specific
treatment modalities, eg, chemotherapy,7 on patients' care needs.
Regarding the predictors of supportive care needs over time, our
findings highlight the role of depressive symptoms as the main pre-
dictor of care needs, which is consistent with previous studies.23
Patients with higher levels of depressive symptoms after diagnosis
reported higher supportive care needs over time, except for Sexual
care needs. Furthermore, time since diagnosis was a consistent pre-
dictor of supportive care needs decline. These findings add to a large
body of literature, both theoretical24-27 and empirical,28 suggesting
that cancer patients are rather resilient and capable of adapting to
their disease.4.1 | Study limitations
The results of this study should be interpreted considering some limi-
tations. In this study, physical and psychological symptoms were
assessed at 1 point in time. Physical symptoms were measured after
surgery, and it might be that for patients who received neoadjuvant
treatment, physical symptoms started to exhibit earlier in the disease
trajectory. Also, the relatively small sample size used might have
prevented us from identifying a significant interaction between time
and group. A higher attrition was observed among the patients in
advanced cancer stage or with lower education, which is common in
longitudinal studies involving (low‐middle income) cancer patients.29,30
Although there are studies indicating that selective attrition does not
always affect the estimates of associations between variables,31,32 we
advise caution in the generalizability of our findings. Because the care
protocols for Mexican cancer patients might change according to the
type of cancer, our findings might not be extrapolated beyond patients
with breast cancer.
To the best of our knowledge, this longitudinal study is the first
evaluating supportive care needs of breast cancer patients living in a
Latin American country. The design of the study provides a whole pic-
ture of the care needs fluctuations since patients were followed from
after diagnosis until the first post‐treatment follow‐up visit, and
patients with different treatment trajectories were included. Assess-
ments were conducted at clinical relevant points. Future research
should investigate in more detail which factors are linked to unmet
Health System and Information needs in these patients, whether it is
related with health literacy issues, patient‐physician communication,
or insufficient information provision.33-35 We additionally suggest
piloting different intervention strategies, ie, written or web‐based
information, smartphone applications, specialized nurse consultations,
to meet the information needs of Mexican breast cancer patients.
Also, further longitudinal studies should be done in the Latin American
region to confirm our results.
PÉREZ‐FORTIS ET AL. 21394.2 | Clinical implications
In Mexico, where the provision of supportive care for cancer patients
within the public health care system has not been systematically
implemented yet, our results have some implications for the delivery
of such care. Health policy makers should take into account that even
though Mexican breast cancer patients showed on average low sup-
portive care needs over time, there was a moderate need of patients
for more information regarding the disease, the medical treatments,
and the organization of the care services within the hospital where
they are being treated. Health professionals within the Mexican public
health system should ensure that their patients receive the informa-
tion they need regarding their illness at each phase of the disease
treatment and that this information is presented in such a way that
it is clear to each patient. Furthermore, clinicians should be aware that
patients with depressive symptoms may be in higher need of support-
ive care over the course of treatment; thus, they should prioritize sup-
portive care services for these patients. Overall, we suggest to screen
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